Manufacturer supply colloidal gold FIA ELISA uncut sheets test stips test midstream

Name: Manufacturer supply colloidal gold FIA ELISA uncut sheets test stips test midstream
Brand: Auker Biotech Co., Ltd.
SKU: 1931019791

Hubei, ChinaAuker Biotech Co., Ltd.

US$9.00

1-99 pcs

US$6.00

100-999 pcs

US$1.80

1,000+ pcs

Sample price:US$10.00/piece.Request sample

Product profile

Customization

Available

Supply Type

OBM(Original Brand Manufacturing)

Usage Mode

For external use

Model NO.

uncut sheet

Suitable for

Elderly, Adult

Type

colloidal gold test kit

Application

for Diagnosis

Form

pvc card

Storage

2-8 degrees

Shelf life

2 years

Delivery time

3-5 days

Usage

Elisa kit, rapid test kit

Transport Package

Carton

Specification

6X30cm

Trademark

Aoke Botai

Origin

China

HS Code

3921909090

Production Capacity

1000 PCS/Month

Company profile

Auker Biotech Co., Ltd.

Hubei, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2020-04-30Nearest Port: Wuhan, ShanghaiAverage Response Time: ≤15hTerms of Payment: T/T, PayPal, Western UnionInternational Commercial Terms(Incoterms): FOB, EXW, CIF

AI-Powered supplier vetting

SummaryAuker Biotech Co., Ltd., based in Wuhan, China, is a high-tech manufacturer and trading company in the healthcare and chemical sectors. Established in 2002, the company specializes in in vitro diagnostic raw materials and has developed strong innovation capabilities with notable technology platforms. Certified under ISO 9001 and ISO 13485, it exports to various global markets, generating 31-40% of sales from exports. The company operates three production lines and offers customization services. Financial data is not provided to assess credibility, and customer cases are limited.

Supplier typeAuker Biotech Co., Ltd. is a manufacturer and trading company specializing in biotechnology products, operating as a limited company in Wuhan, China.

CertificationsThe company holds ISO 9001 and ISO 13485 certifications, indicating compliance with international quality standards.

R&D capabilityAuker Biotech has developed advanced technology platforms in monoclonal antibodies and recombinant proteins, indicating strong innovation capabilities.

Production capacityThe company operates three production lines and maintains a lead time of 15 workdays even during peak seasons, indicating robust production capabilities.

Customization capabilityThe company provides customized services for monoclonal antibodies and recombinant proteins, showing strong customization capabilities.